A. Kerber

Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

Max S. Topp, Tom van Meerten, Roch Houot et al. · British Journal of Haematology · 2021 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17

Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin

Jörg Reichrath, S. Muller, A. Kerber et al. · Journal of the American Academy of Dermatology · 1997 · 114 citations

Pharmacy, Dermatology, Pharmacotherapy +7

Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle

Jörg Reichrath, M. B. Schilli, A. Kerber et al. · British Journal of Dermatology · 2006 · 96 citations

Life Sciences, Dermatology, Endocrinology +15

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer

Christian Manegold, Johan Vansteenkiste, Felipe Cardenal et al. · Investigational New Drugs · 2012 · 63 citations · Full text

Medicine, Oncology, Pharmacology +13

Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma

Max S. Topp, Tom van Meerten, Roch Houot et al. · Blood · 2019 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +13